These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 16872693

  • 1. Identification of tocopherol-associated protein as an activin/TGF-beta-inducible gene in mast cells.
    Funaba M, Murakami M, Ikeda T, Ogawa K, Tsuchida K, Sugino H.
    Biochim Biophys Acta; 2006 Aug; 1763(8):900-6. PubMed ID: 16872693
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of mouse mast cell protease-6 gene by transforming growth factor-beta and activin in mast cell progenitors.
    Funaba M, Ikeda T, Murakami M, Ogawa K, Abe M.
    Cell Signal; 2005 Jan; 17(1):121-8. PubMed ID: 15451032
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
    Murakami M, Ikeda T, Saito T, Ogawa K, Nishino Y, Nakaya K, Funaba M.
    Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
    [Abstract] [Full Text] [Related]

  • 4. Requirement of Smad3 for mast cell growth.
    Funaba M, Nakaya K, Ikeda T, Murakami M, Tsuchida K, Sugino H.
    Cell Immunol; 2006 Mar; 240(1):47-52. PubMed ID: 16839529
    [Abstract] [Full Text] [Related]

  • 5. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
    You L, Kruse FE.
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A, Speletas M, Leandersson K, Ivars F, Sideras P.
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [Abstract] [Full Text] [Related]

  • 7. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
    Kaivo-Oja N, Mottershead DG, Mazerbourg S, Myllymaa S, Duprat S, Gilchrist RB, Groome NP, Hsueh AJ, Ritvos O.
    J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
    [Abstract] [Full Text] [Related]

  • 8. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J.
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [Abstract] [Full Text] [Related]

  • 9. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.
    DaCosta Byfield S, Major C, Laping NJ, Roberts AB.
    Mol Pharmacol; 2004 Mar; 65(3):744-52. PubMed ID: 14978253
    [Abstract] [Full Text] [Related]

  • 10. Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration.
    Funaba M, Ikeda T, Ogawa K, Murakami M, Abe M.
    J Leukoc Biol; 2003 Jun; 73(6):793-801. PubMed ID: 12773512
    [Abstract] [Full Text] [Related]

  • 11. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Matsuyama S, Iwadate M, Kondo M, Saitoh M, Hanyu A, Shimizu K, Aburatani H, Mishima HK, Imamura T, Miyazono K, Miyazawa K.
    Cancer Res; 2003 Nov 15; 63(22):7791-8. PubMed ID: 14633705
    [Abstract] [Full Text] [Related]

  • 12. Involvement of p38 MAP kinase and Smad3 in TGF-beta-mediated mast cell functions.
    Funaba M, Ikeda T, Murakami M, Ogawa K, Nishino Y, Tsuchida K, Sugino H, Abe M.
    Cell Signal; 2006 Dec 15; 18(12):2154-61. PubMed ID: 16750902
    [Abstract] [Full Text] [Related]

  • 13. Both SMAD2 and SMAD3 mediate activin-stimulated expression of the follicle-stimulating hormone beta subunit in mouse gonadotrope cells.
    Bernard DJ.
    Mol Endocrinol; 2004 Mar 15; 18(3):606-23. PubMed ID: 14701940
    [Abstract] [Full Text] [Related]

  • 14. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells.
    Bilezikjian LM, Corrigan AZ, Blount AL, Chen Y, Vale WW.
    Endocrinology; 2001 Mar 15; 142(3):1065-72. PubMed ID: 11181520
    [Abstract] [Full Text] [Related]

  • 15. Microarray analysis of bone morphogenetic protein, transforming growth factor beta, and activin early response genes during osteoblastic cell differentiation.
    de Jong DS, van Zoelen EJ, Bauerschmidt S, Olijve W, Steegenga WT.
    J Bone Miner Res; 2002 Dec 15; 17(12):2119-29. PubMed ID: 12469906
    [Abstract] [Full Text] [Related]

  • 16. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
    Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS.
    Mol Pharmacol; 2002 Jul 15; 62(1):65-74. PubMed ID: 12065756
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional activation of mouse mast cell Protease-7 by activin and transforming growth factor-beta is inhibited by microphthalmia-associated transcription factor.
    Funaba M, Ikeda T, Murakami M, Ogawa K, Tsuchida K, Sugino H, Abe M.
    J Biol Chem; 2003 Dec 26; 278(52):52032-41. PubMed ID: 14527958
    [Abstract] [Full Text] [Related]

  • 18. Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
    Ungefroren H, Hyder A, Hinz H, Groth S, Lange H, El-Sayed KM, Ehnert S, Nüssler AK, Fändrich F, Gieseler F.
    PLoS One; 2015 Dec 26; 10(2):e0118097. PubMed ID: 25707005
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
    Ethier JF, Farnworth PG, Findlay JK, Ooi GT.
    Mol Endocrinol; 2002 Dec 26; 16(12):2754-63. PubMed ID: 12456797
    [Abstract] [Full Text] [Related]

  • 20. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
    Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S.
    Kidney Int; 2002 Sep 26; 62(3):901-13. PubMed ID: 12164872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.